50.8% stake in Indo Borax sold; new board appointed

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

INDOBORAX · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹243.70

prior close

₹243.70

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-0.1% vs market

Commodity Chemicals peers, median of 50sector+0.0%+0.0% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and in line with its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.7

10m

-0.7

15m

-0.7

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0+0.1-0.1+0.0+0.0

Next day

-0.3+2.2-2.4+1.8-2.1

-0.1+1.8-1.8+1.0-1.1

+1.4+3.6-2.3+1.2+0.2

+0.5+2.3-1.8-0.2+0.7

+1.4+6.1-4.7+2.5-1.1

+0.6+6.4-5.8+2.7-2.1

15d

+0.1+7.0-6.9+0.0+0.1

+0.5+3.8-3.3-2.0+2.4

+0.4-5.2+5.6-11.2+11.6

+3.0+12.5-9.5+4.3-1.3

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 50Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoters sold their entire 50.80% stake (1,63,00,230 shares) in Indo Borax to Zenrock Chemicals and three funds (India Special Assets Fund III, ISAFIII Onshore, Special Situation India Fund) on January 23, 2026. Sellers exited promoter group. Suresh Kalra named new MD and CEO; Harsh Malhotra and Sunil Malhotra also joined. Old MD, CEO, Executive Director and four independent directors resigned. Board committees reconstituted.

Likely market impact

Full change of control. Old promoters exit. New professional management led by ex-Aquapharm CEO takes over. Watch for open offer and strategy reset.